Buddy&Soul

Buddy&Soul, conceptualized by Talya Miron-Shatz, was as a cutting-edge digital platform engineered to provide customized support for both personal growth and enhanced patient involvement. This innovative platform tailored its offerings to meet the distinct needs of its users, employing validated methodologies such as cognitive behavioral therapy, motivational interviewing, and the principles of positive psychology. It further arms its users with an arsenal of self-guidance tools, encompassing modules aimed at the management of medical conditions, emotional regulation, and adherence to prescribed medications.

The platform catered to a wide spectrum of users, ranging from individuals grappling with chronic ailments, those in pursuit of better mental and physical well-being, to healthcare professionals keen on augmenting patient engagement and treatment outcomes. Buddy&Soul was versatile in its application, proving beneficial for self-help purposes, patient education, and in the realm of clinical interventions and care coordination.

Evidence of Buddy&Soul’s efficacy is reflected in its notable contributions to patient outcomes and engagement levels, including enhanced comprehension of medical conditions and treatment modalities, heightened adherence to medication regimes, alleviation of stress and anxiety, and encouraging patients to take a more proactive stance in managing their health. The platform has gained recognition, being part of the IBM Alpha Zone Accelerator program and selected for inclusion in the Haleon 2023 Cohort. With its personalized, interactive, and evidence-backed approach, Buddy&Soul has emerged as a favored resource among patients, healthcare practitioners, and institutions aiming to bolster patient engagement and health outcomes.